Antoinette Hollestelle

Antoinette Hollestelle

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 125 publications

Clinical characteristics and follow-up of 77 patients with pathogenic fumarate hydratase variants.

Clinical characteristics and follow-up of 77 patients with pathogenic fumarate hydratase variants.

Journal: BJU international

Published: March 19, 2026

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

Journal: Journal of the National Cancer Institute

Published: February 25, 2026

Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation study.

Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation study.

Journal: Journal of medical genetics

Published: October 30, 2025

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Journal: Nature communications

Published: September 09, 2025

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: July 09, 2025

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.

Journal: Breast (Edinburgh, Scotland)

Published: June 26, 2025

The contribution of rare germline variants to the immune landscape of breast cancer.

The contribution of rare germline variants to the immune landscape of breast cancer.

Journal: Genome medicine

Published: April 28, 2025

Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.

Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.

Journal: iScience

Published: January 31, 2025

Cohort profile: a nationwide study in Dutch CHEK2 c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2.

Cohort profile: a nationwide study in Dutch CHEK2 c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands - Hebon-CHEK2.

Journal: BMJ open

Published: October 09, 2024

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Journal: Breast cancer research : BCR

Published: August 12, 2024

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: February 29, 2024

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2024

Showing 1-12 of 125

Last Updated: 09/26/2026